RecruitingNot applicableNCT05664412
Using Transcranial Alternating Current Stimulation to Improve Executive Function in 22q11.2 Deletion Syndrome
Studying 22q11.2 deletion syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Stephan Eliez
- Intervention
- at-home tACS using Starstim-Home tES(device)
- Enrollment
- 40 enrolled
- Eligibility
- 14-25 years · All sexes
- Timeline
- 2023 – 2026
Study locations (1)
- University of Geneva, Geneva, Canton of Geneva, Switzerland
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05664412 on ClinicalTrials.govOther trials for 22q11.2 deletion syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT05924347Early Scoliotic Changes in Children at Increased Risk for Scoliosis DevelopmentUMC Utrecht
- RECRUITINGNCT05329935Congenital Athymia Patient RegistrySumitomo Pharma Switzerland GmbH
- RECRUITINGNANCT04639388Understanding of Psychotic Disorders in Children With 22q11.2DSHôpital le Vinatier
- RECRUITINGNCT00556530Examining Genetic Factors That Affect the Severity of 22q11.2 Deletion SyndromeAlbert Einstein College of Medicine